abstract |
The present invention provides compounds that modulate Histone Acyltransferase (HAT) and compositions comprising the same. The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, tau protein levels, and/or accumulation of alpha-synuclein, as well as cancer, by administering to a subject a compound that modulates HAT. |